Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

November 10, 2023

Study Completion Date

November 30, 2025

Conditions
Atypical Ductal Breast HyperplasiaBRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma in SituLobular Breast Carcinoma in Situ
Interventions
DRUG

metformin hydrochloride

given PO

OTHER

placebo

given PO

Trial Locations (27)

10029

Mount Sinai Hospital, New York

10032

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

14263

Roswell Park Cancer Institute, Buffalo

27710

Duke University Medical Center, Durham

29316

Prisma Health Cancer Institute - Spartanburg, Boiling Springs

29601

Greenville Health System Cancer Institute-Andrews, Greenville

29605

Prisma Health Cancer Institute - Butternut, Greenville

Prisma Health Cancer Institute - Faris, Greenville

Prisma Health Greenville Memorial Hospital, Greenville

29615

Prisma Health Cancer Institute - Eastside, Greenville

29640

Prisma Health Cancer Institute - Easley, Easley

29650

Prisma Health Cancer Institute - Greer, Greer

29672

Prisma Health Cancer Institute - Seneca, Seneca

43210

Ohio State University Comprehensive Cancer Center, Columbus

45219

The Christ Hospital, Cincinnati

46321

The Community Hospital, Munster

53792

University of Wisconsin Carbone Cancer Center, Madison

55905

Mayo Clinic in Rochester, Rochester

66160

University of Kansas Cancer Center, Kansas City

66606

Cotton O'Neil Cancer Center / Stormont Vail Health, Topeka

73104

University of Oklahoma Health Sciences Center, Oklahoma City

77030

M D Anderson Cancer Center, Houston

78041

Doctor's Hospital of Laredo, Laredo

90033

Los Angeles County-USC Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

91010

City of Hope Comprehensive Cancer Center, Duarte

91030

City of Hope South Pasadena, South Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER